Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (321-330 of 405) with videos related to

Pageof 41
Sort By:
Science (New York, N.Y.)|July 10, 2010
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1Xueling Wu, Zhi-Yong Yang, Yuxing Li, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-AssemblyJoel J Credle, Jonathan Gunn, Puwanat Sangkhapreecha, et al.
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
Frontiers in Immunology|January 10, 2022
Development of an <i>In Vivo</i> Probe to Track SARS-CoV-2 Infection in Rhesus MacaquesPatrick J Madden, Muhammad S Arif, Mark E Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Cell Host & Microbe|June 2, 2023
Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaquesPatricia A Darrah, Joseph J Zeppa, Chuangqi Wang, et al.
Nature Microbiology|February 14, 2024
Author Correction: Intravenous Bacille Calmette-Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosisErica C Larson, Amy L Ellis-Connell, Mark A Rodgers, et al.
Nature Microbiology|October 9, 2023
Intravenous Bacille Calmette-Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosisErica C Larson, Amy L Ellis-Connell, Mark A Rodgers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2013
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunizationKylie M Quinn, Andreia Da Costa, Ayako Yamamoto, et al.
BMJ Open|November 22, 2011
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsAngela M Minassian, Rosalind Rowland, Natalie E R Beveridge, et al.
Pageof 41

Showing results (321-330 of 405) with videos related to

Sort By:
Pageof 41
Science (New York, N.Y.)|July 10, 2010
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1Xueling Wu, Zhi-Yong Yang, Yuxing Li, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-AssemblyJoel J Credle, Jonathan Gunn, Puwanat Sangkhapreecha, et al.
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
Frontiers in Immunology|January 10, 2022
Development of an <i>In Vivo</i> Probe to Track SARS-CoV-2 Infection in Rhesus MacaquesPatrick J Madden, Muhammad S Arif, Mark E Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Cell Host & Microbe|June 2, 2023
Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaquesPatricia A Darrah, Joseph J Zeppa, Chuangqi Wang, et al.
Nature Microbiology|February 14, 2024
Author Correction: Intravenous Bacille Calmette-Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosisErica C Larson, Amy L Ellis-Connell, Mark A Rodgers, et al.
Nature Microbiology|October 9, 2023
Intravenous Bacille Calmette-Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosisErica C Larson, Amy L Ellis-Connell, Mark A Rodgers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2013
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunizationKylie M Quinn, Andreia Da Costa, Ayako Yamamoto, et al.
BMJ Open|November 22, 2011
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsAngela M Minassian, Rosalind Rowland, Natalie E R Beveridge, et al.
Pageof 41